These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Rifaximin for the treatment of hepatic encephalopathy. Mullen K; Prakash R Expert Rev Gastroenterol Hepatol; 2010 Dec; 4(6):665-77. PubMed ID: 21108586 [TBL] [Abstract][Full Text] [Related]
12. Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study. Sanyal A; Younossi ZM; Bass NM; Mullen KD; Poordad F; Brown RS; Vemuru RP; Mazen Jamal M; Huang S; Merchant K; Bortey E; Forbes WP Aliment Pharmacol Ther; 2011 Oct; 34(8):853-61. PubMed ID: 21848797 [TBL] [Abstract][Full Text] [Related]
13. Management of hepatic encephalopathy: focus on antibiotic therapy. Festi D; Vestito A; Mazzella G; Roda E; Colecchia A Digestion; 2006; 73 Suppl 1():94-101. PubMed ID: 16498257 [TBL] [Abstract][Full Text] [Related]
14. Development of an experimental rat model of hyperammonemic encephalopathy and evaluation of the effects of rifaximin. Tamaoki S; Suzuki H; Okada M; Fukui N; Isobe M; Saito T Eur J Pharmacol; 2016 May; 779():168-76. PubMed ID: 26980242 [TBL] [Abstract][Full Text] [Related]
15. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis. Kawaguchi T; Taniguchi E; Sata M Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292 [TBL] [Abstract][Full Text] [Related]
16. Update on management of patients with overt hepatic encephalopathy. Chacko KR; Sigal SH Hosp Pract (1995); 2013 Aug; 41(3):48-59. PubMed ID: 23948621 [TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy of hepatic encephalopathy in cirrhosis. Romero-Gómez M Expert Opin Pharmacother; 2010 Jun; 11(8):1317-27. PubMed ID: 20384539 [TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatic encephalopathy with non-absorbable antibiotics. Festi D; Mazzella G; Parini P; Ronchi M; Cipolla A; Orsini M; Sangermano A; Bazzoli F; Aldini R; Roda E Ital J Gastroenterol; 1992; 24(9 Suppl 2):14-6. PubMed ID: 1486194 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of rifaximin versus lactulose for reducing the recurrence of overt hepatic encephalopathy and hopitalizations in cirrhosis. Irimia R; Trifan A Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1021-7. PubMed ID: 23700882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]